These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10947118)

  • 1. Loss of wild-type p53 function is responsible for upregulated homologous recombination in immortal rodent fibroblasts.
    Willers H; McCarthy EE; Alberti W; Dahm-Daphi J; Powell SN
    Int J Radiat Biol; 2000 Aug; 76(8):1055-62. PubMed ID: 10947118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended lifespan and immortalization of human fibroblasts induced by X-ray irradiation.
    Tsutsui T; Tanaka Y; Matsudo Y; Hasegawa K; Fujino T; Kodama S; Barrett JC
    Mol Carcinog; 1997 Jan; 18(1):7-18. PubMed ID: 9022808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of p53 results in high rates of homologous recombination.
    Mekeel KL; Tang W; Kachnic LA; Luo CM; DeFrank JS; Powell SN
    Oncogene; 1997 Apr; 14(15):1847-57. PubMed ID: 9150391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homologous recombination in extrachromosomal plasmid substrates is not suppressed by p53.
    Willers H; McCarthy EE; Hubbe P; Dahm-Daphi J; Powell SN
    Carcinogenesis; 2001 Nov; 22(11):1757-63. PubMed ID: 11698336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant transformation of human fibroblast cell strain MSU-1.1 by N-methyl-N-nitrosourea: evidence of elimination of p53 by homologous recombination.
    Boley SE; McManus TP; Maher VM; McCormick JJ
    Cancer Res; 2000 Aug; 60(15):4105-11. PubMed ID: 10945617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The p53 tumor suppressor gene and gene product.
    Levine AJ
    Princess Takamatsu Symp; 1989; 20():221-30. PubMed ID: 2488233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of homologous DNA recombination activity in normal and immortal mammalian cells.
    Thyagarajan B; McCormick-Graham M; Romero DP; Campbell C
    Nucleic Acids Res; 1996 Oct; 24(20):4084-91. PubMed ID: 8918816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociation of p53-mediated suppression of homologous recombination from G1/S cell cycle checkpoint control.
    Willers H; McCarthy EE; Wu B; Wunsch H; Tang W; Taghian DG; Xia F; Powell SN
    Oncogene; 2000 Feb; 19(5):632-9. PubMed ID: 10698508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activities of wildtype and mutant p53 in suppression of homologous recombination as measured by a retroviral vector system.
    Lu X; Lozano G; Donehower LA
    Mutat Res; 2003 Jan; 522(1-2):69-83. PubMed ID: 12517413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infrequent loss of heterozygosity and mutation of the p53 gene in immortal and transformed mouse embryo fibroblasts.
    Tokumitsu M; Kadohama T; Ogawa K
    Mol Carcinog; 1994 May; 10(1):52-7. PubMed ID: 8185830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of v-Abl transformation by p53 and p19ARF.
    Cong F; Zou X; Hinrichs K; Calame K; Goff SP
    Oncogene; 1999 Dec; 18(54):7731-9. PubMed ID: 10618713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The introduction of dominant-negative p53 mutants suppresses temperature shift-induced senescence in immortal human fibroblasts expressing a thermolabile SV40 large T antigen.
    Fujii M; Ide A; Nakabayashi K; Joguchi A; Ogino H; Ayusawa D
    J Biochem; 1999 Mar; 125(3):531-6. PubMed ID: 10050041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation of p53 is not a prerequisite for immortalization of human fibroblasts by SV40 T antigen.
    Moorwood K; Price TN; Mayne LV
    Exp Cell Res; 1996 Mar; 223(2):308-13. PubMed ID: 8601408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 loss of function: implications for the processes of immortalization and tumorigenesis.
    Finlay CA
    Bioessays; 1992 Aug; 14(8):557-60. PubMed ID: 1365909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immortal, telomerase-negative cell lines derived from a Li-Fraumeni syndrome patient exhibit telomere length variability and chromosomal and minisatellite instabilities.
    Tsutsui T; Kumakura S; Tamura Y; Tsutsui TW; Sekiguchi M; Higuchi T; Barrett JC
    Carcinogenesis; 2003 May; 24(5):953-65. PubMed ID: 12771041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence.
    Zou X; Ray D; Aziyu A; Christov K; Boiko AD; Gudkov AV; Kiyokawa H
    Genes Dev; 2002 Nov; 16(22):2923-34. PubMed ID: 12435633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase activity during spontaneous immortalization of Li-Fraumeni syndrome skin fibroblasts.
    Gollahon LS; Kraus E; Wu TA; Yim SO; Strong LC; Shay JW; Tainsky MA
    Oncogene; 1998 Aug; 17(6):709-17. PubMed ID: 9715272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of the ARF transcriptional activator DMP1 facilitates cell immortalization, Ras transformation, and tumorigenesis.
    Inoue K; Wen R; Rehg JE; Adachi M; Cleveland JL; Roussel MF; Sherr CJ
    Genes Dev; 2000 Jul; 14(14):1797-809. PubMed ID: 10898794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wild-type p53 can inhibit oncogene-mediated focus formation.
    Eliyahu D; Michalovitz D; Eliyahu S; Pinhasi-Kimhi O; Oren M
    Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8763-7. PubMed ID: 2530586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel host cell reactivation assay to assess homologous recombination capacity in human cancer cell lines.
    Slebos RJ; Taylor JA
    Biochem Biophys Res Commun; 2001 Feb; 281(1):212-9. PubMed ID: 11178982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.